Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Quantifying the amount of variation in survival explained by prostate-specific antigenDavid A Verbel, Glenn Heller, William K Kelly, et al.Biometrics|March 14, 2002
Two-stage designs for gene-disease association studiesJaya M Satagopan, David A Verbel, E S Venkatraman, et al.Epilepsy Research|May 24, 2017
Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design mattersBarry E Gidal, Rama Maganti, Antonio Laurenza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2002
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castrationOren Smaletz, Howard I Scher, Eric J Small, et al.British Journal of Cancer|June 6, 2018
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 studyRaoul Tibes, Mitesh J Borad, Corina E Dutcus, et al.Journal of the National Cancer Institute|February 19, 2004
Loss of the tumor suppressor PML in human cancers of multiple histologic originsCarmela Gurrieri, Paola Capodieci, Rosa Bernardi, et al.The Journal of Clinical Investigation|June 9, 2007
Improved prediction of prostate cancer recurrence through systems pathologyCarlos Cordon-Cardo, Angeliki Kotsianti, David A Verbel, et al.Pageof 1